FindTrial
Sign In

Autologous Hematopoietic Stem Cells

BIOLOGICAL2 trials

Sponsors

Northwestern University, General Oncology, Inc.

Conditions

Adenocarcinoma of the BreastBRCA1 MutationBRCA2 MutationBreast Cancer MetastaticBreast Cancer Stage IVHER2 Negative Breast CarcinomaHER2-negative Breast CancerMetastatic Pancreatic Cancer

Phase 1

Stem Cell Transplantation for Stiff Person Syndrome (SPS)
TerminatedNCT02282514
Northwestern UniversityStiff-Person Syndrome
Start: 2014-10-31End: 2019-08-30Updated: 2021-01-27
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
RecruitingNCT04150042
General Oncology, Inc.Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation +17
Start: 2021-01-13End: 2028-12-01Target: 24Updated: 2026-01-29

Related Papers

The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation.
Journal of Clinical Oncology2023-01-24
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder
Neurology2020-12-1650 citations